CN106177354A - 一种草本抗菌剂 - Google Patents
一种草本抗菌剂 Download PDFInfo
- Publication number
- CN106177354A CN106177354A CN201610628029.3A CN201610628029A CN106177354A CN 106177354 A CN106177354 A CN 106177354A CN 201610628029 A CN201610628029 A CN 201610628029A CN 106177354 A CN106177354 A CN 106177354A
- Authority
- CN
- China
- Prior art keywords
- antibacterial
- parts
- aloe
- benzalkonium chloride
- citric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 29
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 33
- 238000000605 extraction Methods 0.000 claims abstract description 27
- 239000007788 liquid Substances 0.000 claims abstract description 18
- 241001116389 Aloe Species 0.000 claims abstract description 17
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 17
- 244000068988 Glycine max Species 0.000 claims abstract description 14
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 14
- 229960000686 benzalkonium chloride Drugs 0.000 claims abstract description 13
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229920001661 Chitosan Polymers 0.000 claims abstract description 11
- 241000196324 Embryophyta Species 0.000 claims abstract description 11
- FQPGMQABJNQLLF-UHFFFAOYSA-N O-amino-L-homoserine Natural products NOCCC(N)C(O)=O FQPGMQABJNQLLF-UHFFFAOYSA-N 0.000 claims abstract description 8
- FQPGMQABJNQLLF-GSVOUGTGSA-N canaline Chemical compound NOCC[C@@H](N)C(O)=O FQPGMQABJNQLLF-GSVOUGTGSA-N 0.000 claims abstract description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 3
- 229960002449 glycine Drugs 0.000 claims description 3
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- PQXRVHVVXKJMDC-UHFFFAOYSA-N azane;benzene Chemical compound N.C1=CC=CC=C1 PQXRVHVVXKJMDC-UHFFFAOYSA-N 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 239000002068 microbial inoculum Substances 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 208000030961 allergic reaction Diseases 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 206010059866 Drug resistance Diseases 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960000349 nitrofural Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种草本抗菌剂，包括壳聚糖、柠檬酸、大豆氨基酸、大豆萃取液、植物香精、苯扎氯铵、芦荟提取液，各组分的质量份数为：壳聚糖1‑3份、柠檬酸0.4‑0.7份、大豆氨基酸0.1‑0.3份、大豆萃取液1‑1.5份、植物香精0.3‑0.5份、苯扎氯铵1‑2份、芦荟提取液2‑3.5份。本发明产品安全温和，不易引起过敏反应，性能稳定，贮存时间长；而且成本低廉，制造工艺简便，应用领域广泛。
Description
技术领域
本发明涉及一种抗菌剂。特别地，本发明涉及一种抗微生物、抗菌、抗真菌、抗病毒的草本抗菌剂。
背景技术
目前，临床在治疗各种感染性创面时，所采用的常规治疗方法是抗菌、消炎、清创。在治疗过程中所用的外用药物多为抗菌消炎药。但这些药物存在一定的不足之处。如临床上常用的四环素软膏、庆大霉素纱条、呋喃西林纱条等抗生素药物，随着其广泛且大剂量的应用，使敏感菌对其产生相应抗药性，故疗效不佳，再加上抗生素类药物只具有抗菌作用，并不能促进局部组织的血液循环和抑制创面渗出液的渗出，所以，一旦细菌出现抗药性，创面的感染即可进一步恶化，从而造成迁延不愈的恶果。在治疗中细菌虽不易产生抗药性，但其抗菌消炎作用以及促进组织愈合的作用均较弱，故伤口的愈合期较长。天然产品虽然安全，但一般昂贵，对广谱生物体如革兰氏阴性和革兰氏阳性细菌及真菌没有杀生物效果。
发明内容
针对现有技术中存在的上述不足，本发明所要解决的技术问题是提供一种效果好的草本抗菌剂。
本发明解决其技术问题所采用的技术方案是：提供一种草本抗菌剂，包括壳聚糖、柠檬酸、大豆氨基酸、大豆萃取液、植物香精、苯扎氯铵、芦荟提取液，各组分的质量份数为：壳聚糖1-3份、柠檬酸0.4-0.7份、大豆氨基酸0.1-0.3份、大豆萃取液1-1.5份、植物香精0.3-0.5份、苯扎氯铵1-2份、芦荟提取液2-3.5份。
作为优选，所述的草本抗菌剂，各组分的质量份数为：壳聚糖1份、柠檬酸0.4份、大豆氨基酸0.1份、大豆萃取液1份、植物香精0.3份、苯扎氯铵1份、芦荟提取液2份。
作为优选，所述的草本抗菌剂，所述大豆萃取液的主要活性成分为谷氨酰胺、氨基醋酸、色氨酸。
作为优选，所述的草本抗菌剂，所述苯扎氯铵为该发明里的阳离子活性剂，在抗菌剂中的含量为7%-8%。
作为优选，所述的草本抗菌剂，所述芦荟提取液为天然新鲜芦荟，去皮，用 100 份1-3 丁二醇为溶剂在 50℃下萃取5-8h，然后在 -25℃～ -18℃条件下冷冻，在结冰的状态待其自然溶解后再用 0.2mm 滤纸过滤，取其清液。
本发明产品安全温和，不易引起过敏反应，性能稳定，贮存时间长；而且成本低廉，制造工艺简便，应用领域广泛。
具体实施方式
本发明提供的一种草本抗菌剂，包括壳聚糖、柠檬酸、大豆氨基酸、大豆萃取液、植物香精、苯扎氯铵、芦荟提取液，各组分的质量份数为：壳聚糖1-3份、柠檬酸0.4-0.7份、大豆氨基酸0.1-0.3份、大豆萃取液1-1.5份、植物香精0.3-0.5份、苯扎氯铵1-2份、芦荟提取液2-3.5份。
作为优选，所述的草本抗菌剂，各组分的质量份数为：壳聚糖1份、柠檬酸0.4份、大豆氨基酸0.1份、大豆萃取液1份、植物香精0.3份、苯扎氯铵1份、芦荟提取液2份。
作为优选，所述的草本抗菌剂，所述大豆萃取液的主要活性成分为谷氨酰胺、氨基醋酸、色氨酸。
作为优选，所述的草本抗菌剂，所述苯扎氯铵为该发明里的阳离子活性剂，在抗菌剂中的含量为7%-8%。
作为优选，所述的草本抗菌剂，所述芦荟提取液为天然新鲜芦荟，去皮，用 100 份1-3 丁二醇为溶剂在 50℃下萃取5-8h，然后在 -25℃～ -18℃条件下冷冻，在结冰的状态待其自然溶解后再用 0.2mm 滤纸过滤，取其清液。
以上所述，仅是对本发明的较佳实施例而已，并非对本发明做其他形式的限制，任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更或改型为同等变化的等效实施例。凡是未脱离本发明方案内容，依据本发明的技术实质对以上实施例所做的任何简单修改、等同变化与改型，均落在本发明的保护范围内。
Claims (5)
1.一种草本抗菌剂，包括壳聚糖、柠檬酸、大豆氨基酸、大豆萃取液、植物香精、苯扎氯铵、芦荟提取液，各组分的质量份数为：壳聚糖1-3份、柠檬酸0.4-0.7份、大豆氨基酸0.1-0.3份、大豆萃取液1-1.5份、植物香精0.3-0.5份、苯扎氯铵1-2份、芦荟提取液2-3.5份。
2.根据权利要求1所述的草本抗菌剂，各组分的质量份数为：壳聚糖1份、柠檬酸0.4份、大豆氨基酸0.1份、大豆萃取液1份、植物香精0.3份、苯扎氯铵1份、芦荟提取液2份。
3.根据权利要求1-2所述的草本抗菌剂，所述大豆萃取液的主要活性成分为谷氨酰胺、氨基醋酸、色氨酸。
4.根据权利要求1所述的草本抗菌剂，所述苯扎氯铵为该发明里的阳离子活性剂，在抗菌剂中的含量为7%-8%。
5.根据权利要求1所述的草本抗菌剂，所述芦荟提取液为天然新鲜芦荟，去皮，用 100份 1-3 丁二醇为溶剂在 50℃下萃取5-8h，然后在 -25℃～ -18℃条件下冷冻，在结冰的状态待其自然溶解后再用 0.2mm 滤纸过滤，取其清液。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610628029.3A CN106177354A (zh) | 2016-08-04 | 2016-08-04 | 一种草本抗菌剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610628029.3A CN106177354A (zh) | 2016-08-04 | 2016-08-04 | 一种草本抗菌剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106177354A true CN106177354A (zh) | 2016-12-07 |
Family
ID=57497117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610628029.3A Pending CN106177354A (zh) | 2016-08-04 | 2016-08-04 | 一种草本抗菌剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106177354A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107260930A (zh) * | 2017-05-25 | 2017-10-20 | 周淑华 | 一种草本抗菌剂 |
| CN108142463A (zh) * | 2017-12-22 | 2018-06-12 | 泉州市晋江恒安卫生科技有限公司 | 一种天然植物抗菌剂 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101940225A (zh) * | 2010-09-21 | 2011-01-12 | 福州圣德莉信息技术有限公司 | 一种复合抗菌剂及其制备方法 |
| CN103766415A (zh) * | 2012-10-17 | 2014-05-07 | 天津市中科健新材料技术有限公司 | 一种含壳聚糖的草本抗菌剂 |
| CN104546565A (zh) * | 2013-10-11 | 2015-04-29 | 天津市中科健新材料技术有限公司 | 一种用于卫生湿巾的除臭制剂 |
| CN105536036A (zh) * | 2015-12-31 | 2016-05-04 | 佛山铭乾科技有限公司 | 一种医用新材料 |
-
2016
- 2016-08-04 CN CN201610628029.3A patent/CN106177354A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101940225A (zh) * | 2010-09-21 | 2011-01-12 | 福州圣德莉信息技术有限公司 | 一种复合抗菌剂及其制备方法 |
| CN103766415A (zh) * | 2012-10-17 | 2014-05-07 | 天津市中科健新材料技术有限公司 | 一种含壳聚糖的草本抗菌剂 |
| CN104546565A (zh) * | 2013-10-11 | 2015-04-29 | 天津市中科健新材料技术有限公司 | 一种用于卫生湿巾的除臭制剂 |
| CN105536036A (zh) * | 2015-12-31 | 2016-05-04 | 佛山铭乾科技有限公司 | 一种医用新材料 |
Non-Patent Citations (1)
| Title |
|---|
| 徐树楠主编: "《中药临床应用大全》", 31 January 1999, 河北科学技术出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107260930A (zh) * | 2017-05-25 | 2017-10-20 | 周淑华 | 一种草本抗菌剂 |
| CN108142463A (zh) * | 2017-12-22 | 2018-06-12 | 泉州市晋江恒安卫生科技有限公司 | 一种天然植物抗菌剂 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Talapko et al. | Antibacterial activity of silver and its application in dentistry, cardiology and dermatology | |
| Gelmetti | Local antibiotics in dermatology | |
| CN104043098A (zh) | 一种用于治疗妇女阴道炎的抗菌肽冻干制剂及制备方法 | |
| CN106177354A (zh) | 一种草本抗菌剂 | |
| CN108685996A (zh) | 一种用于防治痤疮的外用天然药物组合物及其制备方法 | |
| CN106236774A (zh) | 一种多用途抗菌剂 | |
| Monica et al. | Anti-inflammatory and antimicrobial effects of herbal formulation using karpooravalli, mint, and cinnamon on wound pathogens | |
| CN104474536A (zh) | 仙鹤草鲜药治疗创伤伤口制剂 | |
| Singh et al. | Therapeutical effect of extracts of Terminalia chebula in inhibiting human pathogens and free radicals | |
| CN107279194A (zh) | 一种草本抗菌剂 | |
| CN107260930A (zh) | 一种草本抗菌剂 | |
| CN106344605A (zh) | 一种新型抗菌剂 | |
| Abd | Studying of antibacterial effect for leaves extract of Callistemon viminalis in vitro and vivo (urinary system) for rabbits | |
| CN107095901A (zh) | 一种新型抗菌剂 | |
| CN106176863A (zh) | 一种医用抗菌剂 | |
| JP2013523789A5 (zh) | ||
| Wang et al. | Study on the Effect and Mechanism of Antibacterial Adhesive Hydrogel on Wound Healing | |
| CN107279187A (zh) | 一种多用途抗菌剂 | |
| CN107213315A (zh) | 一种新型抗菌剂 | |
| CN107115356A (zh) | 一种皮肤病学领域用抗菌剂 | |
| Ozcan et al. | Propolis induced mania with psychotic features: A case report | |
| CN106237335A (zh) | 一种皮肤病学领域用抗菌剂 | |
| CN107260893A (zh) | 一种医用抗菌剂 | |
| Ghaemi et al. | The Efficacy of Ethanol Extract of Lemon verbena on the Skin Infection due to Staphylococcus aureus in an Animal Model | |
| CN110876740B (zh) | volvalerenal K在修复皮肤破损中的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161207 |
|
| WD01 | Invention patent application deemed withdrawn after publication |